Abstract: Antimicrobial compounds and compositions of Formulas (V), (VI), (VII), (VIII), and (IX), and methods of use are disclosed.

Abstract: Antimicrobial compounds and compositions of Formulas (V), (VI), (VII), (VIII), and (IX), and methods of use are disclosed.

Abstract: Antimicrobial compounds and compositions of Formulas (V), (VI), (VII), (VIII), and (IX), and methods of use are disclosed.

Abstract: A method of treating an infection of a lung in a patient in need thereof according to an embodiment includes administering to the patient an effective amount of a compound having the formula: or a pharmaceutically acceptable salt thereof.

Abstract: A method of treating an infection of at least one of a wound or a ulcer in a patient in need thereof according to an embodiment includes administering to the patient an effective amount of a compound having the formula: or a pharmaceutically acceptable salt thereof.

Abstract: Methods and pharmaceutical compositions including Bisphosphocins for treating oral mucositis in a patient are disclosed.

Abstract: Methods and pharmaceutical compositions including Bisphosphocins for treating oral mucositis in a patient are disclosed.

Abstract: A method of treating an infection of at least one of a wound or a ulcer in a patient in need thereof according to an embodiment includes administering to the patient an effective amount of a compound having the formula: or a pharmaceutically acceptable salt thereof.

Abstract: Antimicrobial compounds and compositions of Formulas (I) to (III) and methods of use are disclosed. Another aspect of the present disclosure provides a pharmaceutical composition comprising a compound according to Formula (I) to (III), or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable carriers, excipients, or diluents. Another aspect of the present disclosure provides a method of treating a bacterial infection in a patient in need thereof, the method of comprising administering an effective amount of a compound according to Formula (I) to (III), or a pharmaceutically acceptable salt thereof, to the patient.

Abstract: Antimicrobial compounds and compositions of Formula (I) and methods of use are disclosed.

Abstract: Antimicrobial compounds and compositions of Formula (I) and methods of use are disclosed.

Abstract: Antimicrobial compounds and compositions of Formula (I) and methods of use are disclosed.

Abstract: Antimicrobial compounds and compositions of Formula (I) and methods of use are disclosed.

Abstract: Methods and pharmaceutical compositions including Bisphosphocins for treating oral mucositis in a patient are disclosed.

Abstract: Antimicrobial compounds and compositions of Formula (I) and methods of use are disclosed.

Abstract: Antimicrobial compounds and compositions of Formula (I) and methods of use are disclosed.

Abstract: Antimicrobial compounds and compositions of Formula (I) and methods of use are disclosed.

Abstract: A top drive thrust bearing configured for use in a heavy loaded top drive system. The top drive thrust bearing includes an upper plate; a lower plate; and a plurality of rollers disposed between the upper plate and the lower plate. The composition of the top drive thrust bearing comprising a non-vacuum arc remelted steel including, in weight percent (%), about 0.15% to about 0.18% carbon (C), about 0.15% to about 0.4% silicon (Si), about 0.4% to about 0.7% manganese (Mn), 0% to about 0.025% phosphorus (P), about 0.0005% to about 0.002% sulfur (S), about 0.0002% to about 0.0007% oxygen (O), about 0.001% to about 0.003% titanium (Ti), about 1.3% to about 1.6% chromium (Cr), about 3.25% to about 3.75% nickel (Ni), about 0.0005% to about 0.003% calcium (Ca), about 0.15% to about 0.25% molybdenum (Mo), balance iron (Fe).

Abstract: A top drive thrust bearing configured for use in a heavy loaded top drive system. The top drive thrust bearing includes an upper plate; a lower plate; and a plurality of rollers disposed between the upper plate and the lower plate. The composition of the top drive thrust bearing comprising a non-vacuum arc remelted steel including, in weight percent (%), about 0.15% to about 0.18% carbon (C), about 0.15% to about 0.4% silicon (Si), about 0.4% to about 0.7% manganese (Mn), 0% to about 0.025% phosphorus (P), about 0.0005% to about 0.002% sulfur (S), about 0.0002% to about 0.0007% oxygen (O), about 0.001% to about 0.003% titanium (Ti), about 1.3% to about 1.6% chromium (Cr), about 3.25% to about 3.75% nickel (Ni), about 0.0005% to about 0.003% calcium (Ca), about 0.15% to about 0.25% molybdenum (Mo), balance iron (Fe). The top drive thrust bearing of the top drive system is configured to achieve an extended life cycle at least about equivalent to a life factor of three for a vacuum arc remelted steel.

Abstract: A clamping mechanism for an adjustable steering column for a vehicle has an actuator coupled to a clamp for clamping the steering column in a desired position. The actuator is controlled to adjust clamping force of the clamp in the event of vehicle crash to thereby control energy absorption, and the actuator can be electrically controlled. Sensors are used to calculate weight, posture, position, etc. of the driver and thereby predetermine the settings required for energy absorption to protect the driver. The actuator depends on the sensed settings to control the clamping absorption energy.